AM Hirst, FM Frame, M Arya, NJ Maitland, D O'Connell - Tumor Biology, 2016 - Springer
The field of plasma medicine has seen substantial advances over the last decade, with applications developed for bacterial sterilisation, wound healing and cancer treatment. Low …
Background Despite promising treatments for breast cancer, mortality rates remain high and treatments for metastatic disease are limited. High-frequency irreversible electroporation (H …
High-frequency irreversible electroporation (H-FIRE) has emerged as an alternative to conventional irreversible electroporation (IRE) to overcome the issues associated with …
V Granata, R Grassi, R Fusco, SV Setola… - Frontiers in …, 2020 - frontiersin.org
This article provides an overview of imaging assessment of ablated pancreatic cancer. Only studies reporting radiological assessment on pancreatic ablated cancer were retained. We …
T Polajzer, T Jarm, D Miklavcic - Radiology and Oncology, 2020 - sciendo.com
Background. Tumor cells can die via immunogenic cell death pathway, in which damage- associated molecular pattern molecules (DAMPs) are released from the cells. These …
V Granata, R Grassi, R Fusco, A Belli… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Local ablation of pancreatic tumors: State of the art and future perspectives - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …
Pancreatic ductal adenocarcinoma (PDAC) has still a dismal prognosis. Locally advanced pancreatic cancer (LAPC) accounts for the 40% of the new diagnoses. Current treatment …
J Yang, A Eresen, J Shangguan, Q Ma… - …, 2021 - Taylor & Francis
Pancreatic ductal adenocarcinoma (PDAC) is associated with highly immunosuppressive tumor microenvironment (TME) that can limit the efficacy of dendritic cell (DC) vaccine …